Wart

HPV Vaccination: The Door to a Splendid Future Still Remains Closed

Retrieved on: 
Wednesday, September 12, 2018
Cancer, Medicine, Infectious causes of cancer, RTT, Papillomavirus, Vaccines, Cancer vaccines, Human papillomavirus infection, HPV vaccine, Wart, Genital wart, Precancerous condition

HPV infection causes external genital warts, and some types of HPV are strongly associated with cancer or precancerous lesions.

Key Points: 
  • HPV infection causes external genital warts, and some types of HPV are strongly associated with cancer or precancerous lesions.
  • This all can be effectively and safely prevented by HPV vaccination, but vaccination rates are still too low to permanently break the chain of infection - which means the door to a 'splendid future' is still not widely open!
  • HPV infection causes external genital warts, and some HPV types are strongly associated with cancer or precancerous lesions.
  • So why do the doors to a splendid future without genital warts and HPV-associated cancers still remain closed?

RXi Pharmaceuticals Announces Positive Results from Phase 2 Trial with Samcyprone™ for the Treatment of Common Warts

Retrieved on: 
Friday, May 18, 2018
RTT, Cancer, Medicine, Microbiology, Wart, Plantar wart, Human papillomavirus infection, Diphenylcyclopropenone, Papillomaviridae, DPCP, Papilloma

This study evaluated the safety and effectiveness of Samcyprone, a proprietary topical formulation of the small molecule diphenylcyclopropenone (DPCP), for the treatment of common warts.

Key Points: 
  • This study evaluated the safety and effectiveness of Samcyprone, a proprietary topical formulation of the small molecule diphenylcyclopropenone (DPCP), for the treatment of common warts.
  • Complete wart clearance throughout the study was 54.0% for all warts, and up to 71.4% for certain wart types (non-plantar warts).
  • Sc., RXi's Chief Development Officer commented: "We are very pleased with these results, as they are a significant improvement over currently used treatment options.
  • Samcyprone is being studied for the treatment of cutaneous warts, which are benign epidermal tumors caused by human papillomaviruses (HPVs).